EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enterobactin and salmochelin S4 inhibit the growth of Staphylococcus aureus

Yaacov Davidov, Noa Tejman-Yarden, Ari Robinson, Galia Rahav, Israel Nissan

Frontiers in Cellular and Infection Microbiology · 05.03.2025 · 15

DOI: 10.3389/fcimb.2025.1456046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 05.03.2025. Verfasst von Yaacov Davidov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Unit, Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Staphylococcus aureus, Anti-Bacterial Agents, Enterobactin, Siderophores. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is increasing demand for novel antimicrobial agents to tackle the antimicrobial resistance crisis. Here we report that two Enterobacteriaceae -produced siderophores, enterobactin and salmochelin S4, inhibit the growth of Staphylococcus aureus isolates, including methicillin-resistance S. aureus (MRSA) clinical isolates. The IC 50 for different S. aureus isolates were 2-5 µM for salmochelin S4 and 5-10 µM for enterobactin. This inhibitory activity was partially repressed by adding Fe +3 . These siderophores also inhibited the growth of Enterococcus strains, including vancomycin-resistant enterococci (VRE) clinical isolates, though less effectively than for S. aureus . The growth of various Gram-negative bacteria was barely affected by these siderophores. These results shed new light on the role of enterobactin and salmochelin in bacterial physiology and ecology and have potential for the development of novel strategies to combat the rapid rise of multidrug-resistant bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusAnti-Bacterial AgentsEnterobactinSiderophoresMicrobial Sensitivity TestsHumansMethicillin-Resistant Staphylococcus aureusInhibitory Concentration 50Staphylococcal InfectionsEnterococcus

Stichwörter der Autor:innen

Staphylococcus aureusantibioticenterobactinsalmochelinsiderophore

Substanzen

Anti-Bacterial AgentsEnterobactinSiderophores

Autor:innen und Institutionen

  • Infectious Disease Unit, Sheba Medical Center, Tel Hashomer, Israel.
  • Department of Laboratories, Public Health Directorate, Ministry of Health, Jerusalem, Israel.
  • Adelson School of Medicine, Ariel University, Ariel, Israel.
  • Department of Avian Diseases, Kimron Veterinary Institute, Beit Dagan, Israel.

Zitieren

APA

Davidov, Y., Tejman-Yarden, N., Robinson, A., Rahav, G., & Nissan, I. (2025). Enterobactin and salmochelin S4 inhibit the growth of Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1456046

Vancouver

Davidov Y, Tejman-Yarden N, Robinson A, Rahav G, Nissan I. Enterobactin and salmochelin S4 inhibit the growth of Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1456046

BibTeX
@article{Davidov2025,
  author = {Davidov, Yaacov and Tejman-Yarden, Noa and Robinson, Ari and Rahav, Galia and Nissan, Israel},
  title = {Enterobactin and salmochelin S4 inhibit the growth of Staphylococcus aureus},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1456046}
}
Kostenlos starten →